The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease

Glucose uptake in the brain decreases because of normal aging but this decline is accelerated in Alzheimer’s disease (AD) patients. In fact, positron emission tomography (PET) studies have shown that metabolic reductions in AD patients occur decades before the onset of symptoms, suggesting that meta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Bukke, Vidyasagar Naik, Villani, Rosanna, Archana, Moola, Wawrzyniak, Agata, Balawender, Krzysztof, Orkisz, Stanislaw, Ferraro, Luca, Serviddio, Gaetano, Cassano, Tommaso
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589651/
https://ncbi.nlm.nih.gov/pubmed/33086751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21207739
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars